ID: ALA3249178

Max Phase: Preclinical

Molecular Formula: C25H22BrN

Molecular Weight: 335.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Br.C1=C2C(=C(c3ccccc3)c3ccccc32)CN(Cc2ccccc2)C1

Standard InChI:  InChI=1S/C25H21N.BrH/c1-3-9-19(10-4-1)17-26-16-15-22-21-13-7-8-14-23(21)25(24(22)18-26)20-11-5-2-6-12-20;/h1-15H,16-18H2;1H

Standard InChI Key:  VQILBAOKFWGFNU-UHFFFAOYSA-N

Associated Targets(non-human)

Heart 171 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Canis familiaris 36305 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 335.45Molecular Weight (Monoisotopic): 335.1674AlogP: 5.40#Rotatable Bonds: 3
Polar Surface Area: 3.24Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.20CX LogP: 5.23CX LogD: 4.37
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.62Np Likeness Score: -0.01

References

1. Ellefson CR, Woo CM, Cusic JW..  (1978)  Synthesis and antiarrhythmic activity of 2-dialkylaminoalkyl-9-phenyl-1H-indeno[2,1-c]pyridine derivatives.,  21  (4): [PMID:650662] [10.1021/jm00202a005]

Source